美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arrowhead Research Corporation

82.85

+0.09000.11%

盤後：82.79-0.0600-0.07%19:30 EDT

成交量：133.58萬

成交額：1.12億

市值：116.70億

市盈率：-36.28

高：85.98

開：83.75

低：82.36

收：82.76

52周最高：95.49

52周最低：28.12

股本：1.41億

流通股本：1.22億

量比：0.80

換手率：1.09%

股息：- -

股息率：- -

每股收益(TTM):-2.2838

每股收益(LYR):-0.0122

淨資產收益率：-55.21%

總資產收益率：-8.10%

市淨率：25.07

市盈率(LYR):-6,794.88

資料載入中...

總覽公司新聞公告

Arrowhead Pharmaceuticals：Plozasiran在III期研究中展現良好安全性與耐受性

Arrowhead Pharmaceuticals擬於2026年底前憑優先審評券向美國FDA提交補充新藥申請

箭頭製藥（Arrowhead Pharmaceuticals）公布三期Shasta-3和Shasta-4數據：Plozasiran顯著減少重度高甘油三酯血癥患者的急性胰腺炎事件

德國家族性乳糜微粒血癥綜合徵（FCS）患者迎來新療法：Redemplo®（Plozasiran）可有效降低甘油三酯

美國研究綜述-Ametek、Ball Corp、麥當勞

美國研究綜述-Ametek、Ball Corp、麥當勞

Arrowhead製藥計劃在2026年底前使用優先審評券，為Plozasiran提交重度高甘油三酯血癥補充新藥申請

Arrowhead製藥完成全球3期Yosemite研究入組，探索Zodasiran治療純合子家族性高膽固醇血癥

美國研究綜述-Alphabet、IBM、特斯拉

Arrowhead Pharmaceuticals Inc(ARWR)股票7月22日收盤上漲19.04%：投資者必看的核心信息

TradingKey中文

異動解讀｜Arrowhead Research Corporation盤中上漲19.25%，核心管線Plozasiran後期試驗數據亮眼

Arrowhead Pharmaceuticals股價盤前飆升18.1%，血脂藥物達後期試驗目標

Arrowhead股價上漲，因其降血脂藥物達到晚期臨床試驗目標

異動解讀｜Arrowhead Pharmaceuticals盤前上漲8.64%，核心管線Plozasiran多項關鍵試驗數據積極

Arrowhead Pharmaceuticals旗下Plozasiran展現一致安全性，未出現新安全信號

Arrowhead Pharmaceuticals旗下Plozasiran在Shasta-3和Shasta-4試驗中實現中位甘油三酯降低79%和81%

Arrowhead Pharmaceuticals 候選藥物 Plozasiran 顯著降低急性胰腺炎事件，高危患者群體實現100%風險削減

Arrowhead Pharmaceuticals Inc(ARWR)股票7月10日盤中下跌7.27%：背後推手曝光

TradingKey中文

異動解讀｜Arrowhead Research Corporation盤中下跌7.92%，報77.35美元

Arrowhead Pharmaceuticals獲歐盟批准Redemplo® (Plozasiran)用於降低家族性乳糜微粒血癥綜合徵成人患者甘油三酯

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/ARWR/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ARWR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Research Corporation","latestPrice":82.85,"timestamp":1789156800000,"preClose":82.76,"halted":0,"volume":1335818,"hourTrading":{"tag":"盘后","latestPrice":82.79,"preClose":82.85,"latestTime":"19:30 EDT","volume":36473,"amount":3021702.7525,"timestamp":1789169406780,"change":-0.06,"changeRate":-0.000724,"amplitude":0.001328},"delay":0,"changeRate":0.0010874818753019476,"floatShares":122000000,"shares":140857021,"eps":-2.28382,"marketStatus":"休市中","change":0.09,"latestTime":"09-11 16:00:00 EDT","open":83.75,"high":85.98,"low":82.355,"amount":111784496.27774,"amplitude":0.043801,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.28382,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":740203200000,"exchange":"NASDAQ","adjPreClose":82.76,"preHourTrading":{"tag":"盘前","latestPrice":84.26,"preClose":82.76,"latestTime":"09:27 EDT","volume":613,"amount":51338.35155000001,"timestamp":1789133270023,"change":1.5,"changeRate":0.018125,"amplitude":0.027687},"postHourTrading":{"tag":"盘后","latestPrice":82.79,"preClose":82.85,"latestTime":"19:30 EDT","volume":36473,"amount":3021702.7525,"timestamp":1789169406780,"change":-0.06,"changeRate":-0.000724,"amplitude":0.001328},"volumeRatio":0.7965254830843419,"impliedVol":0.497,"impliedVolPercentile":0.1195},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","floatShares":122000000,"roa":"-8.10%","roe":"-55.21%","lyrEps":-0.012193,"volumeRatio":0.7965254830843419,"shares":140857021,"dividePrice":0,"high":85.98,"amplitude":0.043801,"preClose":82.76,"low":82.355,"week52Low":28.12,"pbRate":"25.07","psRate":"17.43","week52High":95.4899,"institutionHeld":0.8623,"latestPrice":82.85,"eps":-2.28382,"divideRate":0,"volume":1335818,"delay":0,"ttmEps":-2.28382,"open":83.75,"prevYearClose":66.39,"prevWeekClose":86.34,"prevMonthClose":82.39,"prevQuarterClose":81.51,"fiveDayClose":86.49,"twentyDayClose":85.59,"sixtyDayClose":76.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARWR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"ARWR","fiscalQuarterEnding":"2026/06","expectedEps":-1.23,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":-1.36},{"market":"US","date":"2026-05-07","symbol":"ARWR","fiscalQuarterEnding":"2026/03","expectedEps":-1.18,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.93},{"market":"US","date":"2026-02-05","symbol":"ARWR","fiscalQuarterEnding":"2025/12","expectedEps":0.6,"name":null,"time":"盤後","type":"earning","dateTimestamp":1770267600000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2025-11-25","symbol":"ARWR","fiscalQuarterEnding":"2025/09","expectedEps":0.12,"name":null,"time":"盤後","type":"earning","dateTimestamp":1764046800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2025-08-07","symbol":"ARWR","fiscalQuarterEnding":"2025/06","expectedEps":-0.94,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-1.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARWR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARWR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":15,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARWR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARWR","date":"2026-09-11","current":-36.27694,"percent":0.194581,"low":-6266.572882,"twenty":-36.330944,"median":-20.946165,"eighty":-5.524344,"high":54.790238,"avg":-235.911244,"sd":1076.719843,"marketCap":11690219688},"quantilePoints":[{"date":"2021-09-17","current":-53.7663,"twenty":-62.324426,"median":-5.500749,"eighty":65.320437,"marketCap":6769553492},{"date":"2021-09-24","current":-54.130649,"twenty":-62.324426,"median":-5.561784,"eighty":65.320437,"marketCap":6815427564},{"date":"2021-10-01","current":-51.836907,"twenty":-62.324426,"median":-9.576545,"eighty":65.320437,"marketCap":6526629425},{"date":"2021-10-08","current":-49.957198,"twenty":-62.324426,"median":-10.599494,"eighty":65.320437,"marketCap":6289960914},{"date":"2021-10-15","current":-54.78482,"twenty":-62.324426,"median":-12.617221,"eighty":65.320437,"marketCap":6897792376},{"date":"2021-10-22","current":-54.677172,"twenty":-62.324426,"median":-13.619752,"eighty":65.320437,"marketCap":6884238673},{"date":"2021-10-29","current":-52.847147,"twenty":-62.324426,"median":-14.182147,"eighty":65.320437,"marketCap":6653825717},{"date":"2021-11-05","current":-66.849736,"twenty":-62.691778,"median":-14.893608,"eighty":65.320437,"marketCap":8416849736},{"date":"2021-11-12","current":-61.227171,"twenty":-62.849328,"median":-15.49945,"eighty":65.320437,"marketCap":7708929388},{"date":"2021-11-19","current":-58.883745,"twenty":-62.849328,"median":-15.600362,"eighty":65.320437,"marketCap":7413875694},{"date":"2021-11-26","current":-53.447273,"twenty":-62.849328,"median":-15.768963,"eighty":65.320437,"marketCap":7527941490},{"date":"2021-12-03","current":-50.092904,"twenty":-62.849328,"median":-16.040498,"eighty":65.320437,"marketCap":7055485290},{"date":"2021-12-10","current":-52.000145,"twenty":-62.849328,"median":-16.358374,"eighty":65.320437,"marketCap":7324116359},{"date":"2021-12-17","current":-51.695877,"twenty":-62.849328,"median":-16.725153,"eighty":65.320437,"marketCap":7281260819},{"date":"2021-12-23","current":-52.133726,"twenty":-62.849328,"median":-16.774057,"eighty":65.320437,"marketCap":7342930987},{"date":"2021-12-31","current":-49.202363,"twenty":-62.849328,"median":-17.043029,"eighty":65.320437,"marketCap":6930054440},{"date":"2022-01-07","current":-43.747802,"twenty":-62.849328,"median":-17.532069,"eighty":65.318147,"marketCap":6161790486},{"date":"2022-01-14","current":-42.901789,"twenty":-62.849328,"median":-17.703232,"eighty":65.318147,"marketCap":6042631179},{"date":"2022-01-21","current":-37.729233,"twenty":-62.849328,"median":-17.9233,"eighty":65.318147,"marketCap":5314086994},{"date":"2022-01-28","current":-37.50079,"twenty":-62.849328,"median":-18.094464,"eighty":65.318147,"marketCap":5281911207},{"date":"2022-02-04","current":-28.67194,"twenty":-62.849328,"median":-18.47347,"eighty":65.318147,"marketCap":5246620871},{"date":"2022-02-11","current":-29.190628,"twenty":-62.849328,"median":-18.89431,"eighty":65.318147,"marketCap":5341534615},{"date":"2022-02-18","current":-25.502177,"twenty":-62.849328,"median":-19.299259,"eighty":65.318147,"marketCap":4666592433},{"date":"2022-02-25","current":-25.352334,"twenty":-62.849328,"median":-19.511471,"eighty":65.318147,"marketCap":4639172906},{"date":"2022-03-04","current":-24.735671,"twenty":-62.849328,"median":-19.873469,"eighty":65.318147,"marketCap":4526331010},{"date":"2022-03-11","current":-24.078666,"twenty":-62.849328,"median":-20.265536,"eighty":65.318147,"marketCap":4406106934},{"date":"2022-03-18","current":-27.30606,"twenty":-62.849328,"median":-20.427007,"eighty":65.318147,"marketCap":4996681344},{"date":"2022-03-25","current":-25.421493,"twenty":-62.849328,"median":-20.792261,"eighty":65.318147,"marketCap":4651828072},{"date":"2022-04-01","current":-28.354963,"twenty":-62.849328,"median":-20.994442,"eighty":65.318147,"marketCap":5188618027},{"date":"2022-04-08","current":-27.807459,"twenty":-62.849328,"median":-21.14622,"eighty":65.318147,"marketCap":5088431297},{"date":"2022-04-14","current":-27.012137,"twenty":-62.849328,"median":-21.291767,"eighty":65.318147,"marketCap":4942896888},{"date":"2022-04-22","current":-24.585828,"twenty":-62.849328,"median":-21.677169,"eighty":65.318147,"marketCap":4498911484},{"date":"2022-04-29","current":-23.692531,"twenty":-62.849328,"median":-21.85137,"eighty":65.318147,"marketCap":4335448924},{"date":"2022-05-06","current":-21.277749,"twenty":-62.849328,"median":-22.070043,"eighty":65.318147,"marketCap":3893572714},{"date":"2022-05-13","current":-29.922841,"twenty":-62.849328,"median":-22.230837,"eighty":65.318147,"marketCap":3345493368},{"date":"2022-05-20","current":-34.24482,"twenty":-62.849328,"median":-22.60735,"eighty":65.318147,"marketCap":3828707802},{"date":"2022-05-27","current":-32.343906,"twenty":-62.849328,"median":-22.835097,"eighty":65.318147,"marketCap":3616178040},{"date":"2022-06-03","current":-32.968086,"twenty":-62.849328,"median":-23.022811,"eighty":65.318147,"marketCap":3685963932},{"date":"2022-06-10","current":-28.863626,"twenty":-62.849328,"median":-23.265009,"eighty":65.318147,"marketCap":3227068824},{"date":"2022-06-17","current":-27.539606,"twenty":-62.849328,"median":-23.436785,"eighty":65.318147,"marketCap":3079038144},{"date":"2022-06-24","current":-32.589795,"twenty":-62.849328,"median":-23.562992,"eighty":65.320437,"marketCap":3643669452},{"date":"2022-07-01","current":-34.008387,"twenty":-62.849328,"median":-23.735995,"eighty":65.320437,"marketCap":3802273752},{"date":"2022-07-08","current":-39.465239,"twenty":-62.849328,"median":-23.824971,"eighty":65.320437,"marketCap":4412371626},{"date":"2022-07-15","current":-40.477169,"twenty":-62.849328,"median":-23.891697,"eighty":65.320437,"marketCap":4525509360},{"date":"2022-07-22","current":-40.354224,"twenty":-62.849328,"median":-23.943598,"eighty":65.320437,"marketCap":4511763654},{"date":"2022-07-29","current":-40.221822,"twenty":-62.849328,"median":-24.254281,"eighty":65.320437,"marketCap":4496960586},{"date":"2022-08-05","current":-31.604916,"twenty":-62.849328,"median":-24.559153,"eighty":65.320437,"marketCap":4864818339},{"date":"2022-08-12","current":-32.519506,"twenty":-62.849328,"median":-24.631934,"eighty":65.320437,"marketCap":5005597460},{"date":"2022-08-19","current":-29.301251,"twenty":-62.849328,"median":-24.78754,"eighty":65.320437,"marketCap":4510224313},{"date":"2022-08-26","current":-27.547714,"twenty":-62.849328,"median":-24.830151,"eighty":65.320437,"marketCap":4240309457},{"date":"2022-09-02","current":-27.107611,"twenty":-62.849328,"median":-25.139096,"eighty":65.320437,"marketCap":4172566121},{"date":"2022-09-09","current":-26.523099,"twenty":-62.849328,"median":-25.306228,"eighty":65.320437,"marketCap":4082594502},{"date":"2022-09-16","current":-23.786207,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3661315630},{"date":"2022-09-23","current":-21.269366,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3273908425},{"date":"2022-09-30","current":-22.727208,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3498308227},{"date":"2022-10-07","current":-21.743852,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3346944210},{"date":"2022-10-14","current":-22.018917,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3389283795},{"date":"2022-10-21","current":-22.961013,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534296874},{"date":"2022-10-28","current":-24.666413,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3796802302},{"date":"2022-11-04","current":-23.35298,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3594630783},{"date":"2022-11-11","current":-23.71744,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3650730733},{"date":"2022-11-18","current":-21.124957,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3251680143},{"date":"2022-11-25","current":-20.28601,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3122544408},{"date":"2022-12-02","current":-20.428904,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3596774147},{"date":"2022-12-09","current":-18.207193,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3205613033},{"date":"2022-12-16","current":-19.12839,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3367801787},{"date":"2022-12-23","current":-23.060036,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4060019152},{"date":"2022-12-30","current":-24.420759,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4299592084},{"date":"2023-01-06","current":-22.506114,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3962493888},{"date":"2023-01-13","current":-22.168943,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3903130684},{"date":"2023-01-20","current":-20.326549,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3578753174},{"date":"2023-01-27","current":-20.236235,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3562852316},{"date":"2023-02-03","current":-22.267052,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3920403974},{"date":"2023-02-10","current":-23.21593,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3587232598},{"date":"2023-02-17","current":-23.657537,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3655468001},{"date":"2023-02-24","current":-22.872457,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534160618},{"date":"2023-03-03","current":-22.676187,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3503833773},{"date":"2023-03-10","current":-18.442364,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2849640388},{"date":"2023-03-17","current":-17.033427,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2631936960},{"date":"2023-03-24","current":-17.026417,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2630853859},{"date":"2023-03-31","current":-17.804487,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2751078140},{"date":"2023-04-06","current":-17.713362,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2736997819},{"date":"2023-04-14","current":-21.379404,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3303459971},{"date":"2023-04-21","current":-20.972845,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3240640076},{"date":"2023-04-28","current":-24.505704,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3786523298},{"date":"2023-05-05","current":-28.503078,"twenty":-62.849328,"median":-25.406021,"eighty":65.320437,"marketCap":4281361861},{"date":"2023-05-12","current":-28.524429,"twenty":-62.849328,"median":-25.564592,"eighty":65.322728,"marketCap":4284568873},{"date":"2023-05-19","current":-25.820017,"twenty":-62.849328,"median":-25.767729,"eighty":65.327309,"marketCap":3878347273},{"date":"2023-05-26","current":-23.891344,"twenty":-62.849498,"median":-25.820017,"eighty":65.341771,"marketCap":3588647132},{"date":"2023-06-02","current":-24.6742,"twenty":-62.849668,"median":-25.85766,"eighty":65.356234,"marketCap":3706237596},{"date":"2023-06-09","current":-25.407238,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3816345029},{"date":"2023-06-16","current":-25.435706,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3820621046},{"date":"2023-06-23","current":-25.300485,"twenty":-62.849839,"median":-25.72783,"eighty":65.370696,"marketCap":3800309966},{"date":"2023-06-30","current":-25.570926,"twenty":-62.850009,"median":-25.674346,"eighty":65.385159,"marketCap":3840932126},{"date":"2023-07-07","current":-24.581681,"twenty":-62.850179,"median":-25.548283,"eighty":65.399621,"marketCap":3692340541},{"date":"2023-07-14","current":-24.546097,"twenty":-62.853133,"median":-25.4286,"eighty":65.437987,"marketCap":3686995520},{"date":"2023-07-21","current":-24.780953,"twenty":-62.853133,"median":-25.333526,"eighty":65.437987,"marketCap":3722272659},{"date":"2023-07-28","current":-25.499758,"twenty":-62.853133,"median":-25.303356,"eighty":65.437987,"marketCap":3830242084},{"date":"2023-08-04","current":-23.001735,"twenty":-62.853133,"median":-25.189784,"eighty":65.437987,"marketCap":3455021606},{"date":"2023-08-11","current":-17.14665,"twenty":-62.853133,"median":-25.145063,"eighty":65.437987,"marketCap":3105378341},{"date":"2023-08-18","current":-17.176244,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3110737987},{"date":"2023-08-25","current":-16.596205,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3005688944},{"date":"2023-09-01","current":-16.359455,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":2962811783},{"date":"2023-09-08","current":-17.886495,"twenty":-62.853133,"median":-25.073568,"eighty":65.437987,"marketCap":3239369468},{"date":"2023-09-15","current":-18.075895,"twenty":-62.856087,"median":-25.01581,"eighty":65.476352,"marketCap":3273671196},{"date":"2023-09-22","current":-16.116786,"twenty":-62.856087,"median":-24.951758,"eighty":65.476352,"marketCap":2918862694},{"date":"2023-09-29","current":-15.939223,"twenty":-62.856087,"median":-24.830151,"eighty":65.476352,"marketCap":2886704823},{"date":"2023-10-06","current":-15.122434,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2738778620},{"date":"2023-10-13","current":-15.317753,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2774152277},{"date":"2023-10-20","current":-15.004059,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2717340040},{"date":"2023-10-23","current":-15.057327,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2726987401},{"date":"2023-11-03","current":-15.483478,"twenty":-62.913621,"median":-24.830151,"eighty":65.661983,"marketCap":2804166290},{"date":"2023-11-10","current":-15.826766,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2866338172},{"date":"2023-11-17","current":-15.424291,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2793447000},{"date":"2023-11-24","current":-17.235431,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":3121457277},{"date":"2023-12-01","current":-11.082764,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2275014400},{"date":"2023-12-08","current":-12.837959,"twenty":-62.897398,"median":-24.823525,"eighty":65.638472,"marketCap":2635312111},{"date":"2023-12-15","current":-14.941857,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3067189595},{"date":"2023-12-22","current":-15.051762,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3089750359},{"date":"2023-12-29","current":-16.224082,"twenty":-62.913621,"median":-24.810593,"eighty":65.661983,"marketCap":3330398510},{"date":"2024-01-05","current":-20.727623,"twenty":-62.929845,"median":-24.815865,"eighty":65.685495,"marketCap":4254862911},{"date":"2024-01-12","current":-22.510451,"twenty":-62.929845,"median":-24.780146,"eighty":65.685495,"marketCap":4620832875},{"date":"2024-01-19","current":-19.905242,"twenty":-62.946069,"median":-24.739411,"eighty":65.709006,"marketCap":4086048483},{"date":"2024-01-26","current":-20.061314,"twenty":-62.929845,"median":-24.737541,"eighty":65.685495,"marketCap":4118086258},{"date":"2024-02-02","current":-19.419562,"twenty":-62.929845,"median":-24.715611,"eighty":65.685495,"marketCap":3986350531},{"date":"2024-02-09","current":-12.877492,"twenty":-62.929845,"median":-24.670306,"eighty":65.685495,"marketCap":3822219796},{"date":"2024-02-16","current":-12.343191,"twenty":-62.929845,"median":-24.583754,"eighty":65.685495,"marketCap":3663631746},{"date":"2024-02-23","current":-12.606167,"twenty":-62.929845,"median":-24.5259,"eighty":65.685495,"marketCap":3741686802},{"date":"2024-03-01","current":-13.39927,"twenty":-62.849839,"median":-24.403759,"eighty":65.661983,"marketCap":3977090939},{"date":"2024-03-08","current":-13.858435,"twenty":-62.78865,"median":-24.183136,"eighty":65.661983,"marketCap":4113377544},{"date":"2024-03-15","current":-11.445732,"twenty":-62.78865,"median":-24.078666,"eighty":65.661983,"marketCap":3397253381},{"date":"2024-03-22","current":-11.783844,"twenty":-62.78865,"median":-23.934586,"eighty":65.661983,"marketCap":3497609882},{"date":"2024-03-28","current":-11.980033,"twenty":-62.78865,"median":-23.867826,"eighty":65.661983,"marketCap":3555841431},{"date":"2024-04-05","current":-10.898908,"twenty":-62.771965,"median":-23.697907,"eighty":65.685495,"marketCap":3234948424},{"date":"2024-04-12","current":-10.719416,"twenty":-62.450545,"median":-23.597561,"eighty":65.685495,"marketCap":3181672751},{"date":"2024-04-19","current":-9.437928,"twenty":-62.450545,"median":-23.514443,"eighty":65.685495,"marketCap":2801309225},{"date":"2024-04-26","current":-9.129035,"twenty":-62.427752,"median":-23.37361,"eighty":65.661983,"marketCap":2709625509},{"date":"2024-05-03","current":-10.072411,"twenty":-62.427752,"median":-23.21593,"eighty":65.661983,"marketCap":2989632534},{"date":"2024-05-10","current":-6.482305,"twenty":-62.427752,"median":-23.186475,"eighty":65.370696,"marketCap":3068567760},{"date":"2024-05-17","current":-6.595323,"twenty":-62.427752,"median":-23.186475,"eighty":64.679241,"marketCap":3105005750},{"date":"2024-05-24","current":-6.508265,"twenty":-62.427752,"median":-23.186475,"eighty":63.492771,"marketCap":3064019674},{"date":"2024-05-31","current":-6.009659,"twenty":-62.427752,"median":-23.186475,"eighty":62.516156,"marketCap":2829281239},{"date":"2024-06-07","current":-6.513541,"twenty":-62.427752,"median":-23.186475,"eighty":61.77678,"marketCap":3066503678},{"date":"2024-06-14","current":-6.991043,"twenty":-62.450545,"median":-23.188804,"eighty":61.001953,"marketCap":3291306095},{"date":"2024-06-21","current":-6.27611,"twenty":-62.473339,"median":-23.191133,"eighty":60.436538,"marketCap":2954723471},{"date":"2024-06-28","current":-6.777354,"twenty":-62.570212,"median":-23.208812,"eighty":59.933947,"marketCap":3190703908},{"date":"2024-07-05","current":-6.61379,"twenty":-62.570212,"median":-23.208812,"eighty":58.878506,"marketCap":3113699766},{"date":"2024-07-12","current":-7.452716,"twenty":-62.570212,"median":-23.208812,"eighty":57.044321,"marketCap":3508656497},{"date":"2024-07-15","current":-7.415782,"twenty":-62.570212,"median":-23.208812,"eighty":56.809508,"marketCap":3491268465},{"date":"2024-08-02","current":-7.244303,"twenty":-62.781052,"median":-23.464332,"eighty":50.761782,"marketCap":3410538315},{"date":"2024-08-09","current":-5.966088,"twenty":-62.781052,"median":-23.464332,"eighty":47.94868,"marketCap":3213549832},{"date":"2024-08-16","current":-5.229847,"twenty":-62.781052,"median":-23.464332,"eighty":-5.237233,"marketCap":2816984108},{"date":"2024-08-23","current":-5.624509,"twenty":-62.781052,"median":-23.464332,"eighty":-5.400175,"marketCap":3029563227},{"date":"2024-08-30","current":-5.557578,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2993511797},{"date":"2024-09-06","current":-5.366017,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2890330120},{"date":"2024-09-13","current":-4.670166,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2515519569},{"date":"2024-09-20","current":-4.879037,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2628024892},{"date":"2024-09-27","current":-4.528226,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2439065675},{"date":"2024-10-04","current":-4.350513,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2343342914},{"date":"2024-10-11","current":-4.085097,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2200380349},{"date":"2024-10-18","current":-4.809798,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2590730310},{"date":"2024-10-25","current":-4.599773,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2477603410},{"date":"2024-10-31","current":-4.548998,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2450254050},{"date":"2024-11-08","current":-4.936736,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2659103710},{"date":"2024-11-15","current":-4.941352,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2661590016},{"date":"2024-11-22","current":-4.218959,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2272483208},{"date":"2024-11-29","current":-5.402946,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":3239028525},{"date":"2024-12-06","current":-4.628725,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2774888056},{"date":"2024-12-13","current":-4.595514,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2754978545},{"date":"2024-12-20","current":-4.04754,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2426471619},{"date":"2024-12-27","current":-4.053767,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2430204652},{"date":"2025-01-03","current":-4.078674,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2445136785},{"date":"2025-01-10","current":-4.099431,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2457580229},{"date":"2025-01-17","current":-3.947908,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2366743086},{"date":"2025-01-24","current":-4.468899,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2679073536},{"date":"2025-01-31","current":-4.199063,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2517308761},{"date":"2025-02-07","current":-4.27277,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2561495982},{"date":"2025-02-14","current":-3.766894,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2409734901},{"date":"2025-02-21","current":-4.131559,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2643016406},{"date":"2025-02-28","current":-3.733384,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2388298222},{"date":"2025-03-07","current":-3.483047,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":2228153621},{"date":"2025-03-14","current":-2.970544,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1900298532},{"date":"2025-03-21","current":-2.978429,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1905342457},{"date":"2025-03-28","current":-2.720206,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1740153931},{"date":"2025-04-04","current":-2.377224,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1520743218},{"date":"2025-04-11","current":-2.189963,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1400950013},{"date":"2025-04-17","current":-2.237271,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1431213559},{"date":"2025-04-25","current":-2.629533,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1682148800},{"date":"2025-05-02","current":-2.767514,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1770417478},{"date":"2025-05-09","current":-2.611792,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1670799970},{"date":"2025-05-16","current":-14.7147,"twenty":-62.792449,"median":-23.478536,"eighty":-5.974802,"marketCap":2118460672},{"date":"2025-05-23","current":-14.762662,"twenty":-62.792449,"median":-23.478536,"eighty":-6.230734,"marketCap":2125365694},{"date":"2025-05-30","current":-16.134371,"twenty":-62.792449,"median":-23.478536,"eighty":-6.469305,"marketCap":2322849316},{"date":"2025-06-06","current":-15.789046,"twenty":-62.792449,"median":-23.478536,"eighty":-6.537285,"marketCap":2273133160},{"date":"2025-06-13","current":-15.558829,"twenty":-62.792449,"median":-23.478536,"eighty":-6.601655,"marketCap":2239989055},{"date":"2025-06-20","current":-14.983287,"twenty":-62.796248,"median":-23.489306,"eighty":-6.621705,"marketCap":2157128794},{"date":"2025-06-27","current":-15.414943,"twenty":-62.796248,"median":-23.489306,"eighty":-6.745697,"marketCap":2219273990},{"date":"2025-07-03","current":-16.105594,"twenty":-62.796248,"median":-23.489306,"eighty":-6.798459,"marketCap":2318706303},{"date":"2025-07-11","current":-18.091215,"twenty":-62.796248,"median":-23.489306,"eighty":-6.917175,"marketCap":2604574204},{"date":"2025-07-18","current":-18.081623,"twenty":-62.796248,"median":-23.489306,"eighty":-7.452716,"marketCap":2603193199},{"date":"2025-07-25","current":-15.597199,"twenty":-62.796248,"median":-23.489306,"eighty":-9.437928,"marketCap":2245513073},{"date":"2025-08-01","current":-15.155949,"twenty":-62.796248,"median":-23.489306,"eighty":-9.880396,"marketCap":2181986873},{"date":"2025-08-08","current":-14.943659,"twenty":-62.634794,"median":-23.37361,"eighty":-9.984752,"marketCap":2217892986},{"date":"2025-08-15","current":-17.49447,"twenty":-62.036463,"median":-23.21593,"eighty":-9.984752,"marketCap":2596476789},{"date":"2025-08-22","current":-19.32962,"twenty":-59.975545,"median":-23.110785,"eighty":-9.984752,"marketCap":2868844162},{"date":"2025-08-29","current":-20.810781,"twenty":-58.784377,"median":-23.001735,"eighty":-9.984752,"marketCap":3088673667},{"date":"2025-09-05","current":-26.083342,"twenty":-56.018638,"median":-22.958793,"eighty":-9.973064,"marketCap":3871211400},{"date":"2025-09-12","current":-27.685605,"twenty":-55.347905,"median":-22.961013,"eighty":-9.984752,"marketCap":4109014386},{"date":"2025-09-19","current":-29.353075,"twenty":-54.78482,"median":-22.961013,"eighty":-9.984752,"marketCap":4356495400},{"date":"2025-09-26","current":-29.492808,"twenty":-54.569523,"median":-22.961013,"eighty":-9.984752,"marketCap":4377234033},{"date":"2025-10-03","current":-32.231559,"twenty":-54.15549,"median":-22.961013,"eighty":-9.984752,"marketCap":4783711230},{"date":"2025-10-10","current":-33.591619,"twenty":-53.575845,"median":-22.961013,"eighty":-9.984752,"marketCap":4985567253},{"date":"2025-10-17","current":-36.302423,"twenty":-53.128689,"median":-22.961013,"eighty":-9.984752,"marketCap":5387896723},{"date":"2025-10-24","current":-34.793315,"twenty":-52.847147,"median":-22.961013,"eighty":-9.984752,"marketCap":5163919492},{"date":"2025-10-31","current":-39.413793,"twenty":-52.590447,"median":-22.961013,"eighty":-9.984752,"marketCap":5849676940},{"date":"2025-11-07","current":-36.889298,"twenty":-52.207937,"median":-22.961013,"eighty":-9.984752,"marketCap":5474998980},{"date":"2025-11-14","current":-38.323882,"twenty":-51.985959,"median":-22.961013,"eighty":-9.984752,"marketCap":5687915607},{"date":"2025-11-21","current":-35.482661,"twenty":-51.814615,"median":-22.961013,"eighty":-9.984752,"marketCap":5266230079},{"date":"2025-11-28","current":-4388.205828,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":7157163706},{"date":"2025-12-05","current":-5384.087075,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":8781446020},{"date":"2025-12-12","current":-5897.015878,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":9618032897},{"date":"2025-12-19","current":-5534.801545,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":9027261320},{"date":"2025-12-26","current":-5837.895838,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":9521608111},{"date":"2026-01-02","current":-5530.993518,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":9021050428},{"date":"2026-01-09","current":-5415.191726,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":8832177705},{"date":"2026-01-16","current":-5582.30567,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":9104740547},{"date":"2026-01-23","current":-5863.738137,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":9563756901},{"date":"2026-01-30","current":-5933.50024,"twenty":-51.71814,"median":-22.961013,"eighty":-9.984752,"marketCap":9677538892},{"date":"2026-02-06","current":44.751592,"twenty":-51.696136,"median":-22.956573,"eighty":-9.926313,"marketCap":9051680761},{"date":"2026-02-13","current":43.186948,"twenty":-51.413872,"median":-22.88537,"eighty":-9.442102,"marketCap":8735208012},{"date":"2026-02-20","current":44.211582,"twenty":-50.288424,"median":-22.837409,"eighty":-9.233391,"marketCap":8942455653},{"date":"2026-02-27","current":43.886192,"twenty":-50.092904,"median":-22.727208,"eighty":-7.075463,"marketCap":8876640524},{"date":"2026-03-06","current":44.031579,"twenty":-49.721845,"median":-22.524904,"eighty":-6.822203,"marketCap":8906047284},{"date":"2026-03-13","current":38.084546,"twenty":-49.202363,"median":-22.390254,"eighty":-6.745697,"marketCap":7703170771},{"date":"2026-03-20","current":39.434571,"twenty":-48.814467,"median":-22.267052,"eighty":-6.632257,"marketCap":7976233542},{"date":"2026-03-27","current":42.072312,"twenty":-45.194931,"median":-22.018917,"eighty":-6.605876,"marketCap":8509756186},{"date":"2026-04-02","current":43.560801,"twenty":-43.747802,"median":-21.778235,"eighty":-6.563666,"marketCap":8810825394},{"date":"2026-04-10","current":45.852381,"twenty":-41.952505,"median":-21.638761,"eighty":-6.495075,"marketCap":9274331943},{"date":"2026-04-17","current":47.063942,"twenty":-41.230312,"median":-21.388249,"eighty":-6.27611,"marketCap":9519388276},{"date":"2026-04-24","current":51.508639,"twenty":-40.221822,"median":-21.351365,"eighty":-6.009659,"marketCap":10418394936},{"date":"2026-05-01","current":50.871705,"twenty":-39.56927,"median":-21.124957,"eighty":-5.719136,"marketCap":10289565321},{"date":"2026-05-08","current":53.966377,"twenty":-39.42741,"median":-20.966795,"eighty":-5.525267,"marketCap":10915509210},{"date":"2026-05-15","current":-37.303167,"twenty":-39.030204,"median":-20.966795,"eighty":-5.525267,"marketCap":11224896003},{"date":"2026-05-22","current":-35.360538,"twenty":-38.323882,"median":-20.966795,"eighty":-5.525267,"marketCap":10640339366},{"date":"2026-05-29","current":-37.003581,"twenty":-37.747321,"median":-20.95648,"eighty":-5.524805,"marketCap":11134747510},{"date":"2026-06-05","current":-35.182658,"twenty":-37.532066,"median":-20.966795,"eighty":-5.525267,"marketCap":10586813698},{"date":"2026-06-12","current":-34.831581,"twenty":-37.034718,"median":-20.966795,"eighty":-5.525267,"marketCap":10481170932},{"date":"2026-06-18","current":-37.935107,"twenty":-36.975495,"median":-20.966795,"eighty":-5.525267,"marketCap":11415052981},{"date":"2026-06-26","current":-37.106564,"twenty":-36.91399,"median":-20.95648,"eighty":-5.524805,"marketCap":11165736054},{"date":"2026-07-02","current":-37.654245,"twenty":-36.904628,"median":-20.95648,"eighty":-5.524805,"marketCap":11330538769},{"date":"2026-07-10","current":-39.320693,"twenty":-36.904628,"median":-20.95648,"eighty":-5.524805,"marketCap":11831989764},{"date":"2026-07-17","current":-33.410887,"twenty":-36.591203,"median":-20.95648,"eighty":-5.524805,"marketCap":10053669873},{"date":"2026-07-24","current":-40.622021,"twenty":-36.403472,"median":-20.95648,"eighty":-5.524805,"marketCap":12223572282},{"date":"2026-07-31","current":-40.874797,"twenty":-36.3376,"median":-20.946165,"eighty":-5.524344,"marketCap":12299635073},{"date":"2026-08-07","current":-37.892425,"twenty":-36.3376,"median":-20.946165,"eighty":-5.524344,"marketCap":12123870902},{"date":"2026-08-14","current":-37.786469,"twenty":-36.3376,"median":-20.946165,"eighty":-5.524344,"marketCap":12089969830},{"date":"2026-08-21","current":-38.616456,"twenty":-36.3376,"median":-20.946165,"eighty":-5.524344,"marketCap":12355528228},{"date":"2026-08-28","current":-39.110916,"twenty":-36.3376,"median":-20.946165,"eighty":-5.524344,"marketCap":12513733231},{"date":"2026-09-04","current":-38.183804,"twenty":-36.330944,"median":-20.946165,"eighty":-5.524344,"marketCap":12217098850},{"date":"2026-09-11","current":-36.537075,"twenty":-36.330944,"median":-20.946165,"eighty":-5.524344,"marketCap":11690219688}],"updateTime":1789270509943},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARWR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1117094130","title":"Arrowhead Pharmaceuticals：Plozasiran在III期研究中展現良好安全性與耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1117094130","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117094130?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 23:33","pubTimestamp":1788103990,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals近日宣布，其研发的Plozasiran在III期临床研究中表现出令人满意的安全性和耐受性特征。这一积极的结果无疑为该公司在代谢疾病领域的布局注入了强心剂。值得关注的是，这项III期研究的数据进一步验证了Plozasiran作为潜在治疗方案的可行性。Plozasiran所呈现的有利安全谱，或将为特定疾病群体带来新的希望。随着研究数据的持续积累与解读，Plozasiran的临床应用前景正逐渐变得清晰。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","ARWR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116619525","title":"Arrowhead Pharmaceuticals擬於2026年底前憑優先審評券向美國FDA提交補充新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1116619525","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116619525?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 23:32","pubTimestamp":1788103929,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals（股票代码：ARWR）宣布，计划于2026年底之前，借助优先审评券，向美国食品药品监督管理局（FDA）提交补充新药申请（sNDA）。这一举措标志着公司在推进其候选药物监管审批进程中迈出关键一步。优先审评券的运用，有望显著缩短FDA对新药申请的审评周期，从而加速产品走向市场的步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","ARWR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107393929","title":"箭頭製藥（Arrowhead Pharmaceuticals）公布三期Shasta-3和Shasta-4數據：Plozasiran顯著減少重度高甘油三酯血癥患者的急性胰腺炎事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1107393929","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107393929?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 23:31","pubTimestamp":1788103875,"startTime":"0","endTime":"0","summary":"两项研究均采用随机、双盲、安慰剂对照设计，旨在评估Plozasiran对极高甘油三酯水平患者的治疗潜力。结果显示，与安慰剂组相比，接受Plozasiran治疗的患者群体中，急性胰腺炎事件的发生率呈现具有统计学意义的下降。这些结果表明，Plozasiran在重度高甘油三酯血症人群中具有可接受的风险-获益比。总而言之，Shasta-3和Shasta-4的积极结果，为Plozasiran的临床开发注入了强心剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ARWR","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178953219","title":"德國家族性乳糜微粒血癥綜合徵（FCS）患者迎來新療法：Redemplo®（Plozasiran）可有效降低甘油三酯","url":"https://stock-news.laohu8.com/highlight/detail?id=1178953219","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178953219?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 21:34","pubTimestamp":1786973661,"startTime":"0","endTime":"0","summary":"在德国，患有家族性乳糜微粒血症综合征的患者如今迎来了一项令人振奋的治疗新选择——Redemplo。这一创新药物旨在显著降低患者体内异常升高的甘油三酯水平，为这一罕见且棘手的代谢性疾病患者群体带来了新的曙光。Redemplo作为一种靶向RNA干扰疗法，通过精准抑制肝脏中APOC3基因的表达，从而有效调节脂质代谢，降低血浆甘油三酯浓度。随着Redemplo在德国正式可供使用，相关医疗体系也正积极整合这一新选项，力求在最短时间内将其纳入规范治疗流程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","ARWR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657519496","title":"美國研究綜述-Ametek、Ball Corp、麥當勞","url":"https://stock-news.laohu8.com/highlight/detail?id=2657519496","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657519496?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:57","pubTimestamp":1785916639,"startTime":"0","endTime":"0","summary":"美国研究综述-Ametek、Ball Corp、麦当劳路透8月5日-周三，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括阿美特克、鲍尔公司和麦当劳。要点* 阿美特克AME.N：加拿大皇家银行将目标价从260美元上调至291美元* 博尔公司BALL.N：摩根大通将评级从“增持”下调至“中性”* 麦当劳MCD.N：摩根大通将目标价从305美元下调至280美元以下是路透周三报道的针对美国公司的研究报告摘要。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4S4420OI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MKL","HLNE","BL","KTOS","OPLN","BRKR","AMGN","SPCX","AME","BBY","OBX","W","YETI","LSCC","TOST","AMD","CMI","ARWR","BKNG","PRCT","BR","IT","PLTR","PINS","PCTY","FBIN","LMAT","ANET","PPLI","CAT","NPO","BDX","BALL","WAT","XMTR","TPG","HSIC","GILD","MCD","TVTX","SYY","ZBRA","MRK","JXN","HNGE","QLYS","CINF","ALAB","EMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657499519","title":"美國研究綜述-Ametek、Ball Corp、麥當勞","url":"https://stock-news.laohu8.com/highlight/detail?id=2657499519","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657499519?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:57","pubTimestamp":1785916639,"startTime":"0","endTime":"0","summary":"美国研究综述-Ametek、Ball Corp、麦当劳路透8月5日-周三，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括阿美特克、鲍尔公司和麦当劳。要点* 阿美特克AME.N：加拿大皇家银行将目标价从260美元上调至291美元* 博尔公司BALL.N：摩根大通将评级从“增持”下调至“中性”* 麦当劳MCD.N：摩根大通将目标价从305美元下调至280美元以下是路透周三报导的针对美国公司的研究报告摘要。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4T4420OI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPO","TPG","SPCX","PINS","PPLI","CINF","AMD","CMI","ZBRA","FBIN","PCTY","BL","PLTR","SYY","AMGN","MRK","LSCC","ANET","WAT","ALAB","HSIC","BBY","MCD","MKL","KTOS","QLYS","OBX","BR","CAT","TVTX","HNGE","BDX","BALL","AME","JXN","YETI","BKNG","ARWR","LMAT","PRCT","HLNE","IT","OPLN","TOST","W","EMR","GILD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154955623","title":"Arrowhead製藥計劃在2026年底前使用優先審評券，為Plozasiran提交重度高甘油三酯血癥補充新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1154955623","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154955623?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873671,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals（股票代码：ARWR）宣布，该公司计划在2026年年底之前，利用一张优先审评券（Priority Review Voucher），为旗下药物Plozasiran提交针对重度高甘油三酯血症（Severe Hypertriglyceridemia）的补充新药申请（sNDA）。这一举动显示出该公司正加速推进其关键管线的监管审批进程。通过使用这一宝贵资源，Arrowhead希望缩短审评周期，使治疗方案更快惠及患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","ARWR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147562503","title":"Arrowhead製藥完成全球3期Yosemite研究入組，探索Zodasiran治療純合子家族性高膽固醇血癥","url":"https://stock-news.laohu8.com/highlight/detail?id=1147562503","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147562503?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 19:31","pubTimestamp":1785151872,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals（股票代码：ARWR，中文名：Arrowhead Research Corporation）宣布，其针对Zodasiran治疗纯合子家族性高胆固醇血症的全球3期Yosemite研究已全面完成患者入组。这一里程碑标志着该候选药物在临床开发上迈出了关键一步，旨在为这一罕见且严重的遗传性脂质代谢疾病提供新的治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","ARWR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653712957","title":"美國研究綜述-Alphabet、IBM、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2653712957","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653712957?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 15:30","pubTimestamp":1784791811,"startTime":"0","endTime":"0","summary":"美国研究综述-Alphabet、IBM、特斯拉路透7月23日-周四，华尔街证券分析师调整了包括Alphabet、IBM和特斯拉在内的多家美国上市公司评级及目标股价。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL4T43P0KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEV","EWBC","MNPR","ROL","BMI","SF","DIG","SNDK","XOM","CASH","GOOGL","MCB","PEGA","IBB","EFX","KNX","GOOX","RJF","CLIX","AMDS","CCI","MPC","WUGI","CELH","SKYY","IPAR","KDP","CVX","PSX","CME","SEIC","FTAI","ARWR","CDNA","EFIV","NTRS","T","BP","BAI","AMD","NOC","CVNA","GSHD","GILD","ARTY","GOOW","EOG","BLFS","FTNT","IBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653372796","title":"Arrowhead Pharmaceuticals Inc(ARWR)股票7月22日收盤上漲19.04%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2653372796","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653372796?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 04:16","pubTimestamp":1784751390,"startTime":"0","endTime":"0","summary":"• 在公布积极的3期临床试验结果后，Arrowhead Pharmaceuticals股价上涨。\n• 分析师基于成功的临床数据和市场潜力上调了目标价。\n• 尽管近期基本面出现积极进展，但技术指标目前仍发出卖出信号。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262048033-market-movers-arwr-20260722","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4139","ARWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125758170","title":"異動解讀｜Arrowhead Research Corporation盤中上漲19.25%，核心管線Plozasiran後期試驗數據亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1125758170","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125758170?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 21:39","pubTimestamp":1784727594,"startTime":"0","endTime":"0","summary":"7月22日，Arrowhead Research Corporation盘中上涨19.25%，报89.54美元/股，成交额1.14亿美元。消息面上，公司公布核心药物Plozasiran在两项关键后期临床试验Shasta-3和Shasta-4中成功达到主要终点，分别实现79%和81%的中位甘油三酯降低率；在高危患者群体中实现急性胰腺炎事件100%的风险削减，且安全性特征稳定，未出现新安全信号。Plozasiran此前已以商品名Redemplo获得欧盟上市许可，用于治疗家族性乳糜微粒血症综合征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141151307","title":"Arrowhead Pharmaceuticals股價盤前飆升18.1%，血脂藥物達後期試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=1141151307","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141151307?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724738,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals的股价在盘前交易时段大幅上涨18.1%，此前该公司宣布其研发的一款血脂药物在后期临床试验中成功达到了主要目标。\n这一积极进展显著提振了投资者信心，推动该公司股票在开盘前即录得强劲涨幅。该药物的成功标志着Arrowhead在心血管疾病治疗领域的研发取得了关键性突破。\n市场分析人士指出，后期试验目标的达成通常意味着药物距离最终获批上市更近一步，这为公司未来的商业化前景带来了明确利好。此次股价的剧烈反应，也反映了市场对该创新疗法潜在价值的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","ARWR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653122757","title":"Arrowhead股價上漲，因其降血脂藥物達到晚期臨床試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2653122757","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653122757?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:01","pubTimestamp":1784721673,"startTime":"0","endTime":"0","summary":"BUZZ-Arrowhead股价上涨，因其降血脂药物达到晚期临床试验目标7月22日-** 制药公司Arrowhead Pharmaceuticals（ARWR.O）的股价在盘前交易中上涨18.1%，至88美元** 该公司表示，其获批的RNA类药物plozasiran在两项针对更广泛严重高甘油三酯血症（一种血液中脂肪）患者群体开展的晚期临床试验中，达到了主要终点及所有次要终点** 该药物商品名为Re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4S43O15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","ARWR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119942739","title":"異動解讀｜Arrowhead Pharmaceuticals盤前上漲8.64%，核心管線Plozasiran多項關鍵試驗數據積極","url":"https://stock-news.laohu8.com/highlight/detail?id=1119942739","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119942739?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:36","pubTimestamp":1784720197,"startTime":"0","endTime":"0","summary":"7月22日，Arrowhead Pharmaceuticals盘前上涨8.64%，报84.0美元/股，成交额6.85万美元。消息面上，公司公布旗下药物Plozasiran在两项关键临床试验Shasta-3和Shasta-4中分别实现79%和81%的中位甘油三酯降低率；同时该药物在高危患者群体中实现急性胰腺炎事件100%的风险削减，且未出现新的安全信号，安全性特征稳定。Plozasiran此前已以商品名Redemplo获得欧盟上市许可，用于治疗家族性乳糜微粒血症综合征。此次多项积极数据同步发布，进一步拓宽了该药物在心血管代谢疾病领域的适应症前景。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128819834","title":"Arrowhead Pharmaceuticals旗下Plozasiran展現一致安全性，未出現新安全信號","url":"https://stock-news.laohu8.com/highlight/detail?id=1128819834","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128819834?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:33","pubTimestamp":1784719981,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals宣布，其研发中的药物Plozasiran在临床试验中持续展现出稳定的安全性特征，期间未观察到新的安全信号。这一结果进一步支持了该药物的开发前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128516817","title":"Arrowhead Pharmaceuticals旗下Plozasiran在Shasta-3和Shasta-4試驗中實現中位甘油三酯降低79%和81%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128516817","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128516817?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:31","pubTimestamp":1784719877,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals公司宣布，其研究性药物Plozasiran在两项关键临床试验——Shasta-3与Shasta-4中，取得了显著成果。数据显示，该药物分别实现了79%和81%的中位甘油三酯降低率，展现出强大的治疗潜力。\n这一积极结果标志着公司在心血管代谢疾病治疗领域的重要进展，也为Plozasiran的后续开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4585","ARWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173896289","title":"Arrowhead Pharmaceuticals 候選藥物 Plozasiran 顯著降低急性胰腺炎事件，高危患者群體實現100%風險削減","url":"https://stock-news.laohu8.com/highlight/detail?id=1173896289","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173896289?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:31","pubTimestamp":1784719873,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals 宣布，其研发中的候选药物 Plozasiran 在临床试验中展现出令人瞩目的效果，能够显著降低急性胰腺炎事件的发生率。尤为引人注目的是，在那些被定义为高风险的患者群体中，该药物实现了急性胰腺炎事件100%的削减，这一数据凸显了其潜在的突破性治疗价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","ARWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650005131","title":"Arrowhead Pharmaceuticals Inc(ARWR)股票7月10日盤中下跌7.27%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2650005131","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650005131?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 01:16","pubTimestamp":1783703774,"startTime":"0","endTime":"0","summary":"• 由于对研发管线的担忧以及RNAi（RNA干扰）疗法领域竞争加剧，投资者情绪出现转变。\n• 潜在的股权稀释和宏观经济不确定性正使Arrowhead Pharmaceuticals的近期股价表现承压。\n• Arrowhead公布年度营收为8.2945亿美元，净亏损为163万美元。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262023465-market-movers-arwr-20260710","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARWR","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104621273","title":"異動解讀｜Arrowhead Research Corporation盤中下跌7.92%，報77.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104621273","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104621273?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 00:13","pubTimestamp":1783700022,"startTime":"0","endTime":"0","summary":"7月11日，Arrowhead Research Corporation盘中下跌7.92%，报77.35美元/股，成交额9839.65万美元。Arrowhead Research Corporation所在的生物科技行业中，整体表现疲弱，个股中，艾伯维公司跌1.33%，Ionis Pharmaceuticals跌8.74%，Moderna跌10.51%，吉利德科学跌3.24%，阿尔尼拉姆制药公司跌4.30%。Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立，后在特拉华州重新注册成立。该公司开发药物，通过沉默疾病的基因来治疗疑难杂症。目前有18个Arrowhead发现的候选药物处于早期（1期）至晚期（3期）的临床试验阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141922913","title":"Arrowhead Pharmaceuticals獲歐盟批准Redemplo® (Plozasiran)用於降低家族性乳糜微粒血癥綜合徵成人患者甘油三酯","url":"https://stock-news.laohu8.com/highlight/detail?id=1141922913","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141922913?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 00:34","pubTimestamp":1782146067,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals宣布，其药物Redemplo® (Plozasiran)已获得欧盟委员会授予的上市许可，用于降低患有家族性乳糜微粒血症综合征（FCS）的成人患者的甘油三酯水平。FCS是一种罕见且严重的遗传性疾病，其特征是血液中甘油三酯水平极度升高，可导致危及生命的胰腺炎。该授权标志着Arrowhead Pharmaceuticals在罕见病治疗领域取得的重要进展，为欧洲的FCS患者提供了一种新的治疗选择。公司表示，将致力于尽快将这一创新疗法带给有需要的患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","ARWR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}